Cdc7-IN-20
Cdc7-IN-20 (EP-05) is an orally effective and selective Cdc7 inhibitor with IC50 and Ki values of 0.93 and 0.11 nM, respectively. Cdc7-IN-20 has antitumor activity[1].
Product Specifications
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdc7-in-20.html
Solubility
10 mM in DMSO
Smiles
O=C1NC(C(N)C(C)C)=NC2=C1SC(C3=CC=NC=C3)=C2
Molecular Formula
C15H16N4OS
Molecular Weight
300.38
References & Citations
[1]Fu M, et al. Discovery of a potent and selective cell division cycle 7 inhibitor from 6- (3-fluoropyridin-4-yl) thieno [3, 2-d] pyrimidin-4 (3H) -one derivatives as an orally active antitumor agent. Acta Pharmaceutica Sinica. B, 2024, 14 (2) : 893.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1042872-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O17:K52:H18 Cysteine desulfuration protein sufE (sufE)
Sign In for Pricing
View Details MBS1042872-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O17:K52:H18 Cysteine desulfuration protein sufE (sufE)
Sign In for Pricing
View Details MBS1042872-03 0.02 mg (Yeast)
Recombinant Escherichia coli O17:K52:H18 Cysteine desulfuration protein sufE (sufE)
Sign In for Pricing
View Details MBS1042872-04 0.1 mg (Yeast)
Recombinant Escherichia coli O17:K52:H18 Cysteine desulfuration protein sufE (sufE)
Sign In for Pricing
View Details MBS1042872-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O17:K52:H18 Cysteine desulfuration protein sufE (sufE)
Sign In for Pricing
View Details MBS1042872-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli O17:K52:H18 Cysteine desulfuration protein sufE (sufE)
Sign In for Pricing
View Details